FILE:BIIB/BIIB-8K-20080724133740.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
     On July 23, 2008, the Board of Directors of Biogen Idec Inc. (the "Company") increased the size of the Company's Board of Directors to 13 members and elected Brian S. Posner as a Class 1 director (term expires in 2010) to fill the resulting vacancy, effective immediately. Mr. Posner will serve as a member of the Finance and Audit Committee of the Board.
     Upon his appointment to the Board, Mr. Posner was awarded an initial grant of stock options to purchase 35,000 shares of the Company's common stock, an additional grant of stock options to purchase 4,900 shares of the Company's common stock and a grant of 1,750 restricted stock units, each under the Biogen Idec Inc. 2006 Non-Employee Directors Equity Plan.
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 24, 2008


